tiprankstipranks
Scientific Industries Inc (SCND)
OTHER OTC:SCND
US Market
Holding SCND?
Track your performance easily

Scientific Industries (SCND) Earnings Dates, Call Summary & Reports

12 Followers

Earnings Data

Report Date
Apr 07, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
Last Year’s EPS
-0.2
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 14, 2019
|
% Change Since: 30.67%
|
Next Earnings Date:Nov 14, 2019
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in the VIVID pill counter business and successful cost-cutting initiatives, alongside promising developments and strategic partnerships in the bioprocessing segment. However, challenges in the European market remain a concern.
Company Guidance
During the third quarter of 2024, Scientific Industries demonstrated significant progress in its strategic transformation into a life sciences tool business with notable growth in sales, margins, and recurring revenue. The legacy Genie business experienced a recovery, generating positive cash flow that supports investments in the VIVID pill counter business, which saw a 50% increase in sales compared to the previous quarter and 12% year-over-year growth. The company is excited about the upcoming launch of the VIVID workstation, a new all-in-one pill counter and pharmacy management system. In the bioprocessing segment, sales increased by 12% compared to the previous year, with a remarkable 61% year-over-year growth in the U.S. market. Efforts to improve cost efficiency resulted in a reduction of operating expenses by over $1 million, or 22%, compared to the previous year. The company also reported a positive EBITDA margin of 14% for its U.S. entity in September, marking a significant milestone. Scientific Industries continues to invest in R&D and commercial activities, with a growing commercial pipeline and the successful launch of the DOTS platform, reflecting its potential to deliver long-term shareholder value.
VIVID Pill Counter Business Growth
VIVID sales in the third quarter were up 50% compared to the second quarter of this year and 12% compared to the same quarter last year. The development of a new VIVID workstation is expected to be a game-changer in the market.
Cost-Cutting Initiatives
The company successfully reduced operating expenses by over $1 million, or roughly 22%, compared to the same time frame last year, and improved cash burn rate without affecting the top line.
Bioprocessing Segment Performance
Sales compared to last year were up 12%, with improved gross margins and lower expenditures, resulting in a 27% improvement in EBITDA. The U.S. team reported a breakeven result with a positive EBITDA margin of 14%.
Strong Pipeline and New Product Development
A 90% increase in the commercial pipeline value was reported, alongside significant advancements in key projects such as the development of PAH technology and the new generation of the liquid injection system.
Strategic Partnerships
Secured partnerships and endorsements from major industry players like Merck, which are expected to positively influence the company's commercial track.
---

Scientific Industries (SCND) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SCND Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 14, 20192020 (Q1)
- / -
0.095
Nov 14, 20192019 (Q4)
- / -0.04
0.095-140.00% (-0.13)
Feb 14, 20202020 (Q2)
- / <0.01
0.078-97.44% (-0.08)
May 15, 20202020 (Q3)
- / -0.09
0.062-245.16% (-0.15)
Oct 09, 20202020 (Q4)
- / -0.09
-0.038-136.84% (-0.05)
Feb 23, 20212021 (Q2)
- / -0.05
0.002-2600.00% (-0.05)
May 17, 20212021 (Q3)
-0.27 / -0.51
-0.09-466.67% (-0.42)
Oct 15, 20212021 (Q4)
-0.33 / -0.19
-0.09-111.11% (-0.10)
Nov 16, 20212022 (Q1)
- / -
-0.09
Feb 17, 20222022 (Q2)
-0.29 / -0.14
-0.05-180.00% (-0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

SCND Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 15, 2024$0.75$0.750.00%
Aug 15, 2024$1.54$1.50-2.60%
May 16, 2024$1.94$1.89-2.58%
Apr 01, 2024$1.78$1.99+11.80%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Scientific Industries Inc (SCND) report earnings?
Scientific Industries Inc (SCND) is schdueled to report earning on Apr 07, 2025, TBA Not Confirmed.
    What is Scientific Industries Inc (SCND) earnings time?
    Scientific Industries Inc (SCND) earnings time is at Apr 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SCND EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis